Unichem Laboratories Ltd receives ANDA approval for Ranolazine Extended-Release Tablets

Unichem Laboratories Limited has received ANDA approval for its Ranolazine Extended-Release Tablets, 500 mg and 1000 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Ranexa® (ranolazine extended-release tablets) 500 mg and 1000 mg, of Gilead Sciences Inc.

Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg are indicated for the treatment of chronic angina. The product will be commercialized from Unichem's Goa Plant.

Shares of Unichem Laboratories Limited was last trading in BSE at Rs. 292.75 as compared to the previous close of Rs. 276.15. The total number of shares traded during the day was 15830 in over 1284 trades.

The stock hit an intraday high of Rs. 301.00 and intraday low of 272.25. The net turnover during the day was Rs. 4602869.00.

Source : Equity Bulls

Keywords

UnichemLaboratories INE351A01035 USFDA ANDAApproval RanolazineExtendedReleaseTablets